"And according to preliminary work by Mateo Aboy, the director of research in biomedical innovation, AI and law at the University of Cambridge, around 3,000 patents have been filed to date on AI methods related to drug development and delivery alone. Aboy says they’re distributed among universities, big pharma, big tech and startups."